A-Alpha Bio logo

A-Alpha Bio

aalphabio.com

A-Alpha Bio develops biotechnology platforms that use synthetic biology and machine learning to measure, predict, and engineer protein-protein interactions. Its AlphaSeq platform enables rapid, quantitative measurement of millions of protein binding affinities, while AlphaBind predicts binding strength from sequence using a large protein interaction database. The company partners with pharmaceutical organizations and runs in-house therapeutic programs to support the discovery and development of novel medicines.

Facts

HQ
Seattle
Sectors
Biotechnology Research
Founded
2017
Type
Corporation Seattle business license
Employees
50
Registered name
A Alpha Bio Inc Seattle business license
Stage
Series A
Members see funding amounts.
.
Founders
David Younger, PhD, Randolph Lopez, PhD

Is this your organization? Claim it

Founders

  • David Younger
    David Younger Executive Officer, Director, Chief Executive Officer & Co-Founder
  • Randolph Lopez Chief Technology Officer & Co-Founder

Online